Aurora Cannabis Inc
Change company Symbol lookup
Select an option...
ACB Aurora Cannabis Inc
NTRA Natera Inc
ADPT Adaptive Biotechnologies Corp
TDOC Teladoc Health Inc
SPNE SeaSpine Holdings Corp
GBT Global Blood Therapeutics Inc
NYMT New York Mortgage Trust Inc
HY Hyster-Yale Materials Handling Inc
NTES NetEase Inc
EV Eaton Vance Corp
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Aurora Cannabis Inc is a Canada-based medical cannabis company. Through its subsidiaries, the Company manages two operating segments plus Corporate: Medical Cannabis, Horizontally Integrated Businesses and Other. The Medical Cannabis segment produces and distributes medical cannabis in Canada and distributes it via wholesale in the European Union. Additionally, it includes the production and sale of indoor cultivation systems and hemp related food products. The Company’s production capacity is of over 625,000 kilograms per year.

Price
Delayed
$1.57
Day's Change
0.06 (3.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.58
Day's Low
1.49
Volume
(Average)

Today's volume of 11,976,442 shares is on pace to be in-line with ACB's 10-day average volume of 34,323,057 shares.

11,976,442

There is no peer information for ACB.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.